Biotech Data: What It Is, Where to Find It, and How to Use It

What Biotech Data Actually Means

Biotech data encompasses any structured information that helps predict or track the performance of biotechnology and pharmaceutical companies. Unlike traditional equities where earnings and revenue dominate, biotech stocks are primarily event-driven. A single FDA decision can move a stock 50-300% in either direction in a single day. The data that matters most predicts those events — or provides early signals of their likely outcome.

PDUFA Date Data

PDUFA dates are the FDA's self-imposed deadlines to approve or reject a drug application. They're the most important single data points in biotech investing. PDUFA date data includes: the target date, the drug name and indication, the application type (NDA/BLA), the review pathway (standard vs priority), and any history of extensions or Complete Response Letters. BiotechSign aggregates PDUFA dates from FDA announcements and SEC filings in real time.

Clinical Trial Data

Clinical trial data covers the design, enrollment status, and results of drug trials across all phases. Key data points: NCT numbers (trial identifiers), primary and secondary endpoints, enrollment counts, planned completion dates, and interim results. Phase 3 trial results are usually announced through press releases and 8-K SEC filings — both searchable in BiotechSign's data layer.

FDA Advisory Committee (Adcom) Data

Adcom meetings are public hearings where independent FDA advisors vote on whether to recommend a drug for approval. The vote is non-binding but highly predictive. Adcom data includes meeting date, committee, drug under review, the specific question the committee votes on, and historical vote breakdowns. BiotechSign's adcom calendar tracks upcoming and past meetings with full context.

Insider Trading and Form 4 Data

Form 4 filings report executive and director stock transactions within two business days. Insider buying cluster signals — multiple executives buying in the same company within a short window — are one of the most reliable leading indicators before positive biotech events. BiotechSign cross-references Form 4 filings with upcoming PDUFA and adcom events to identify meaningful patterns.

How to Access Biotech Data Through BiotechSign

BiotechSign aggregates PDUFA calendar data, adcom meetings, clinical trial signals, insider activity, and current short-interest activity in a single interface. Search by ticker, indication, or FDA review stage. The app surfaces converging signals — a company with a near-term PDUFA date, recent insider buying, and unusual short-interest activity — that individually are interesting but together represent a high-signal event setup.